Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PTPN22 encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. Additionally we are shipping PTPN22 Proteins (4) and PTPN22 Kits (1) and many more products for this protein.
Showing 10 out of 63 products:
Human Polyclonal PTPN22 Primary Antibody for EIA, WB - ABIN954376
Bianco, Verreschi, Oliveira, Guedes, Galera, Galera, Barbosa, Lipay: PTPN22 polymorphism is related to autoimmune disease risk in patients with Turner syndrome. in Scandinavian journal of immunology 2010
Show all 3 references for ABIN954376
Human Polyclonal PTPN22 Primary Antibody for WB - ABIN525622
Cao, Yang, Colby, Hogan, Hu, Jennette, Berg, Zhang, Jennette, Falk, Preston: High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. in PLoS ONE 2012
our data suggest a critical role for GITR (show TNFRSF18 Antibodies) in Treg cell homeostasis and indicate that Ptpn22 independently affects the differentiation status of Treg cells and their homeostatic behavior
Tec (show NR4A3 Antibodies) enhances c-Maf (show MAF Antibodies)-dependent IL-4 (show IL4 Antibodies) promoter activity. This effect of Tec (show NR4A3 Antibodies) is counteracted by Ptpn22, which physically interacts with and facilitates tyrosine dephosphorylation of c-Maf (show MAF Antibodies) thereby attenuating its transcriptional activity.
lack of PTPN22 strengthens transplant tolerance to pancreatic islets by expanding both FOXP3 (show FOXP3 Antibodies)(+) Treg and Tr1 (show TXNRD1 Antibodies) cells
Ptpn22 and Cd2 (show CCND2 Antibodies) Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes
T cell activation modulates the expression of PTPN22 and additional inhibitory phosphatases.
PTPN22 is an inhibitor of PAD-4 (show PADI4 Antibodies) and protein citrullination.
Autoimmunity-associated protein tyrosine phosphatase (show ACP1 Antibodies) PEP (show PREP Antibodies) negatively regulates IFN-alpha (show IFNA Antibodies) receptor signaling.
lack of Ptpn22 exacerbates virally-induced type 1 diabetes in lymphocytic choriomeningitis virus mice, while maintaining higher number of Treg cells in the antiviral response in the blood and spleen but not in the pancreatic lymph nodes
Data suggest that a gain-of-function of human PTPN22 transgene encoding the tyrosine phosphatase LYP is unlikely to increase risk of autoimmunity through alterations of thymic selection.
PTPN22 limited signaling via the T cell antigen receptor (TCR) by weak agonists and self antigens while not impeding responses to strong agonist antigens.
In conclusion, the authors found a lack of association of PTPN22 -1123G>C and +1858C>T polymorphisms with the risk of developing systemic lupus erythematosus in a Mexican population.
this study shows that PTPN22 genetic polymorphisms play role in predisposition of type 1 diabetes mellitus in Egyptian children
Results do not support a major role of PTPN22 gene SNPs in Behcet's disease in Spanish population.
Suppression of PTPN22 with siRNA effectively decreases the viability of T-cell acute leukemia cells.
this study shows that genetic polymorphism in PTPN22 influences genetic susceptibility systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population
we can conclude that PTPN22-rs2476601 polymorphism is clearly associated with the risk of Rheumatoid Arthritis in the Western Algerian population
The PTPN22 1858C/T polymorphism is not associated with RA risk in Asian populations. However, our meta-analysis confirms that the PTPN22 1858C/T polymorphism is associated with RA susceptibility in Caucasians.
LPS (show IRF6 Antibodies) tolerance interferes with TLR4 (show TLR4 Antibodies) signaling by inhibiting Lyn (show LYN Antibodies) and c-Src (show SRC Antibodies) phosphorylation and their recruitment to TLR4 (show TLR4 Antibodies), while increasing the phosphatase activity and expression of PP2A (show PPP2R4 Antibodies), PTPN22, PTP1B (show PTPN1 Antibodies) and MKP1 (show DUSP1 Antibodies).
Using an integrated, unbiased genomic approach, we have identified novel genes associated with ascending aortic aneurysms in patients with bicuspid aortic valves, modulated through epigenetic mechanisms. The top gene was PTPN22, which is involved in T-cell receptor signaling and associated with various immune disorders.
sex-specific pattern of association is broadly applicable to different populations, and provides further impetus to undertake mechanistic studies to understand the impact of sex on PTPN22 in JIA.
This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described.
PEST domain-enriched tyrosine phosphatase
, hematopoietic cell protein-tyrosine phosphatase 70Z-PEP
, protein tyrosine phosphatase, non-receptor type 8
, tyrosine-protein phosphatase non-receptor type 22
, PEST-domain phosphatase
, lymphoid phosphatase
, lymphoid-specific protein tyrosine phosphatase